Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Pilot Study of Working Women and Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by University of Kentucky
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Robin Vanderpool, University of Kentucky
ClinicalTrials.gov Identifier:
NCT01914614
First received: July 26, 2013
Last updated: March 4, 2014
Last verified: March 2014

July 26, 2013
March 4, 2014
November 2013
September 2015   (final data collection date for primary outcome measure)
Guideline concordant breast cancer treatment as defined by National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology and oncologist assessments. [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Differences in receipt of guideline-concordant breast cancer treatment between working poor and working non-poor survivors as explained by variations in occupation and work organization factors associated with each group of women. Guideline-concordant treatment will be informed by National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology and oncologist assessments.
Same as current
Complete list of historical versions of study NCT01914614 on ClinicalTrials.gov Archive Site
  • Breast cancer treatment adherence, including completion of prescribed chemotherapy regimens, prescribed radiation treatment regimen, and/or surgical follow-up appointments. [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Differences in breast cancer treatment adherence rates between working poor and non-poor survivors as explained by variations in occupation and work organization factors associated with each group of women.
  • Satisfaction with breast cancer treatment decision-making [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Differences in satisfaction with breast cancer treatment decision-making between working poor and working non-poor survivors as explained by variations in occupation and work organization factors associated with each group of women.
  • Quality of life [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Differences in quality of life measures between working poor and working non-poor survivors explained by variations in occupation and work organization factors associated with each group of women.
Same as current
Not Provided
Not Provided
 
A Pilot Study of Working Women and Breast Cancer
A Pilot Study of Working Women and Breast Cancer

The purpose of this research is to better understand the relationship between employment and breast cancer. Research is being conducted to understand how workplace factors influence breast cancer patients' ability to adhere to recommended cancer treatment and effectively recover from cancer. Investigators hope to use the findings from the study to help working breast cancer survivors make informed decisions about treatment and employment in collaboration with their employers and healthcare providers.

Patients enrolled will be interviewed three times over a six month period. They will be asked questions about their experiences in managing their cancer while taking care of their job responsibilities. Patients will be asked to complete a survey that asks questions about their breast cancer treatment, their job, and how they manage their responsibilities while undergoing cancer treatment.

The first initial meeting will be conducted at a time and location that is convenient for the patient. This meeting should last about an hour to an hour and a half.

Three and six months after the initial interview, study participants will be asked to complete a follow-up survey by either telephone or Internet/Web, depending on their preference. These telephone surveys will last between 15-30 minutes.

Observational
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Women diagnosed with a new, primary breast cancer within 3 months of enrollment and who were employed at the time of diagnosis.

Breast Cancer
Not Provided
  • Working Poor Survivors
    Low Wage workers
  • Non-Working Poor Survivors
    Higher-Wage Salary Workers
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
50
September 2015
September 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women age 18-65
  • Working at least 20 hours per week
  • Currently patients of the University of Kentucky Markey Cancer Center
  • Are able to read, write, and communicate in English
  • Have reliable telephone or Internet/Web access in or outside the home

Exclusion Criteria:

  • Self-employed
  • Unemployed
  • Cognitively impaired
Female
18 Years to 65 Years
No
Contact: Robin Vanderpool, DrPH 859-218-2102 robin@kcr.uky.edu
United States
 
NCT01914614
IRB # 13-0560-P3H, K12DA035150
No
Robin Vanderpool, University of Kentucky
Robin Vanderpool
National Institute on Drug Abuse (NIDA)
Principal Investigator: Robin Vanderpool, DrPH University of Kentucky
University of Kentucky
March 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP